Docosapentaenoic Acid (n-3)

Category
lipid
Routes
Oral (PO)
Half-Life (t½)
PO: 7d
Formula
C22H34O2
Molecular Weight
330.51 g/mol
PubChem CID
5497182
Aliases
DPA, n-3 DPA, 22:5 ω-3, clupanodonic acid

Pharmacological Mechanism

22:5 ω-3 PUFA positioned between EPA (20:5) and DHA (22:6) in the ω-3 elongation/desaturation pathway. Retroconverts to EPA in humans and is a direct substrate for resolvin and protectin biosynthesis; preferentially incorporated into platelets and vascular endothelium. Typically a minor component of fish oil (~1–5% of EPA+DHA) but enriched in seal oil and in some green-lipped-mussel preparations. Primary human data are epidemiologic (plasma n-3 DPA inversely associated with CV events) rather than pharmacokinetic.

Half-Life & Elimination Curve (PO: 7d)

100%50%25%12.5%0%0h0×t½7d1×t½14d2×t½21d3×t½28d4×t½35d5×t½0×t½ (0h): 100% remaining1×t½ (7d): 50% remaining2×t½ (14d): 25% remaining3×t½ (21d): 12.5% remaining4×t½ (28d): 6.3% remaining5×t½ (35d): 3.1% remaining
Elimination (PO)
  • 0×t½0h100%
  • 1×t½7d50%
  • 2×t½14d25%
  • 3×t½21d12.5%
  • 4×t½28d6.3%
  • 5×t½35d3.1%
Elimination t½7d (PO)
Rate Constant (ke)0.00413 h⁻¹
97% Washout (5×t½)35d

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Interactions

Top Dietary Sources

Chemical Structure & Identifiers

References